BioNTech SE
NASDAQ:BNTX

Watchlist Manager

BioNTech SE

NASDAQ:BNTX

Watchlist

Dividends

Price: 113.51 USD 0.38%

Market Cap: 27.4B USD

Have any thoughts about
BioNTech SE?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 113.51 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

BNTX Alert

BioNTech SE

113.51

+0.43 (+0.38%)

52 Week Range	78.36 124.71
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

BioNTech SE

What unique competitive advantages
does BioNTech SE hold over its rivals?

What risks and challenges
does BioNTech SE face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of BioNTech SE.

What unique competitive advantages
does BioNTech SE hold over its rivals?

What risks and challenges
does BioNTech SE face in the near future?

Summarize the latest earnings call
of BioNTech SE.

What significant events have occurred
in BioNTech SE over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for BioNTech SE.

Provide P/S
for BioNTech SE.

Provide P/E
for BioNTech SE.

Provide P/OCF
for BioNTech SE.

Provide P/FCFE
for BioNTech SE.

Provide P/B
for BioNTech SE.

Provide EV/S
for BioNTech SE.

Provide EV/GP
for BioNTech SE.

Provide EV/EBITDA
for BioNTech SE.

Provide EV/EBIT
for BioNTech SE.

Provide EV/OCF
for BioNTech SE.

Provide EV/FCFF
for BioNTech SE.

Provide EV/IC
for BioNTech SE.

Show me price targets
for BioNTech SE made by professional analysts.

What are the Revenue projections
for BioNTech SE?

How accurate were the past Revenue estimates
for BioNTech SE?

What are the Net Income projections
for BioNTech SE?

How accurate were the past Net Income estimates
for BioNTech SE?

What are the EPS projections
for BioNTech SE?

How accurate were the past EPS estimates
for BioNTech SE?

What are the EBIT projections
for BioNTech SE?

How accurate were the past EBIT estimates
for BioNTech SE?

Compare the revenue forecasts
for BioNTech SE with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of BioNTech SE and its key competitors using the latest financial data.

Compare historical revenue growth rates
of BioNTech SE against its competitors.

Analyze the profit margins
(gross, operating, and net) of BioNTech SE compared to its peers.

Compare the P/E ratios
of BioNTech SE against its peers.

Discuss the investment returns and shareholder value creation
comparing BioNTech SE with its peers.

Analyze the financial leverage
of BioNTech SE compared to its main competitors.

Show all profitability ratios
for BioNTech SE.

Provide ROE
for BioNTech SE.

Provide ROA
for BioNTech SE.

Provide ROIC
for BioNTech SE.

Provide ROCE
for BioNTech SE.

Provide Gross Margin
for BioNTech SE.

Provide Operating Margin
for BioNTech SE.

Provide Net Margin
for BioNTech SE.

Provide FCF Margin
for BioNTech SE.

Show all solvency ratios
for BioNTech SE.

Provide D/E Ratio
for BioNTech SE.

Provide D/A Ratio
for BioNTech SE.

Provide Interest Coverage Ratio
for BioNTech SE.

Provide Altman Z-Score Ratio
for BioNTech SE.

Provide Quick Ratio
for BioNTech SE.

Provide Current Ratio
for BioNTech SE.

Provide Cash Ratio
for BioNTech SE.

What is the historical Revenue growth
over the last 5 years for BioNTech SE?

What is the historical Net Income growth
over the last 5 years for BioNTech SE?

What is the current Free Cash Flow
of BioNTech SE?

Discuss the annual earnings per share (EPS)
trend over the past five years for BioNTech SE.

EV/EBITDA
Enterprise Value to EBITDA

-17.1

Current

1.6

Median

4.2

Industry

Lower than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

-17.1

Enterprise Value

10B USD

EBITDA

-564m EUR

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
DE		BioNTech SE NASDAQ:BNTX	27.2B USD	-17.1
FR		Pharnext SCA OTC:PNEXF	6T USD	-220 140.1
US		Abbvie Inc NYSE:ABBV	315.2B USD	15.4
US		Amgen Inc NASDAQ:AMGN	141.9B USD	16.1
US		Gilead Sciences Inc NASDAQ:GILD	116.4B USD	10.3
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	104.5B USD	21.5
US	E	Epizyme Inc F:EPE	94.1B EUR	-513.3
AU		CSL Ltd ASX:CSL	135.7B AUD	19.9
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	78.7B USD	15.4
US	S	Seagen Inc F:SGT	39.3B EUR	-58.6
NL		argenx SE XBRU:ARGX	36B EUR	-109.3

				EBITDA Growth	EV/EBITDA to Growth
DE		BioNTech SE NASDAQ:BNTX	Average EV/EBITDA: 16.4 Negative Multiple: -17.1	N/A	N/A
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -220 140.1	N/A	N/A
US		Abbvie Inc NYSE:ABBV	15.4	29%	0.5
US		Amgen Inc NASDAQ:AMGN	16.1	62%	0.3
US		Gilead Sciences Inc NASDAQ:GILD	10.3	16%	0.6
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	21.5	43%	0.5
US	E	Epizyme Inc F:EPE	Negative Multiple: -513.3	N/A	N/A
AU		CSL Ltd ASX:CSL	19.9	42%	0.5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	15.4	35%	0.4
US	S	Seagen Inc F:SGT	Negative Multiple: -58.6	N/A	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -109.3	N/A	N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

-8.4

2-Years Forward

EV/EBITDA

-8.4

3-Years Forward

EV/EBITDA

-9.5

	Franklin Covey Co NYSE:FC	36.3 USD -0.3%
	Mohawk Industries Inc NYSE:MHK	119.54 USD 0.32%
	Ardmore Shipping Corp NYSE:ASC	11.88 USD 5.04%
	ASGN Inc NYSE:ASGN	83.56 USD -0.37%
	Skyworks Solutions Inc NASDAQ:SWKS	90.19 USD 1.62%
	Weatherford International PLC NASDAQ:WFRD	68.07 USD 1.45%

	Johnson & Johnson NYSE:JNJ	145.17 USD -0.07%
	Bank of America Corp NYSE:BAC	43.98 USD 0.21%
	Mastercard Inc NYSE:MA	528.96 USD 0.18%
	Salesforce Inc NYSE:CRM	342 USD -0.26%
	Abbvie Inc NYSE:ABBV	177.8955 USD -0.28%
	Home Depot Inc NYSE:HD	392.25 USD -0.09%

	Arista Networks Inc NYSE:ANET	113.69 USD 0.53%
	Visa Inc NYSE:V	316.43 USD -0.25%
	Texas Pacific Land Corp NYSE:TPL	1 139.45 USD 0.56%
	KLA Corp NASDAQ:KLAC	643.293 USD 2.21%
	Manhattan Associates Inc NASDAQ:MANH	278.82 USD -0.51%
	Pinduoduo Inc NASDAQ:PDD	101.27 USD 0.69%

	Salesforce Inc NYSE:CRM	342 USD -0.26%
	Accenture PLC NYSE:ACN	358.77 USD -2.07%
	ServiceNow Inc NYSE:NOW	1 088.26 USD -0.27%
	EOG Resources Inc NYSE:EOG	119.85 USD 0.68%
	Copart Inc NASDAQ:CPRT	57.99 USD -0.63%
	Applied Materials Inc NASDAQ:AMAT	167.59 USD 0.08%

BioNTech SE
NASDAQ:BNTX

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

BioNTech SE NASDAQ:BNTX

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

BioNTech SE
NASDAQ:BNTX

EV/EBITDA
Enterprise Value to EBITDA